BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 1901144)

  • 1. Acoustic-distortion products: separation of sensory from neural dysfunction in sensorineural hearing loss in human beings and rabbits.
    Ohlms LA; Lonsbury-Martin BL; Martin GK
    Otolaryngol Head Neck Surg; 1991 Feb; 104(2):159-74. PubMed ID: 1901144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of TEOAE and DPOAE measurements for the assessment of auditory thresholds in sensorineural hearing loss.
    Suckfüll M; Schneeweiss S; Dreher A; Schorn K
    Acta Otolaryngol; 1996 Jul; 116(4):528-33. PubMed ID: 8831837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostics of the cochlear amplifier by means of distortion product otoacoustic emissions.
    Janssen T; Niedermeyer HP; Arnold W
    ORL J Otorhinolaryngol Relat Spec; 2006; 68(6):334-9. PubMed ID: 17065826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An objective method of analyzing cochlear versus noncochlear patterns of distortion-product otoacoustic emissions in patients with acoustic neuromas.
    Telischi F
    Laryngoscope; 2000 Apr; 110(4):553-62. PubMed ID: 10763999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distortion product emissions and sensorineural hearing loss.
    Kimberley BP; Nelson DA
    J Otolaryngol; 1989 Dec; 18(7):365-9. PubMed ID: 2593222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the differential diagnosis of Ménière's disease using low-frequency acoustic biasing of the 2f1-f2 DPOAE.
    Brown DJ; Gibson WP
    Hear Res; 2011 Dec; 282(1-2):119-27. PubMed ID: 21944944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distortion-product otoacoustic emissions and glycerol testing in endolymphatic hydrops.
    Magliulo G; Cianfrone G; Triches L; Altissimi G; D'Amico R
    Laryngoscope; 2001 Jan; 111(1):102-9. PubMed ID: 11192876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Assessment of cochlear function with distortion products of otoacoustic emissions in acoustic neuroma].
    Oeken J
    HNO; 1996 Dec; 44(12):677-84. PubMed ID: 9081952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical application of acoustic distortion products.
    Ohlms LA; Lonsbury-Martin BL; Martin GK
    Otolaryngol Head Neck Surg; 1990 Jul; 103(1):52-9. PubMed ID: 2117731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distortion-product otoacoustic emissions and cochlear microphonics: relationships in patients with and without endolymphatic hydrops.
    Fetterman BL
    Laryngoscope; 2001 Jun; 111(6):946-54. PubMed ID: 11404602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Objective audiometry with DPOAEs : New findings for generation mechanisms and clinical applications.
    Zelle D; Dalhoff E; Gummer AW
    HNO; 2017 Aug; 65(Suppl 2):122-129. PubMed ID: 28470484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synaptopathy in the noise-exposed and aging cochlea: Primary neural degeneration in acquired sensorineural hearing loss.
    Kujawa SG; Liberman MC
    Hear Res; 2015 Dec; 330(Pt B):191-9. PubMed ID: 25769437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Increased summation potentials in patients with Menière's disease].
    Hesse G; Mausolf A
    Laryngol Rhinol Otol (Stuttg); 1988 Mar; 67(3):129-31. PubMed ID: 3374226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of inner ear hearing loss on delayed otoacoustic emissions (TEOAE) and distortion products (DPOAE)].
    Hoth S
    Laryngorhinootologie; 1996 Dec; 75(12):709-18. PubMed ID: 9081275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Electrocochleography possibilities in the differential diagnosis of hydrops and neural hearing loss].
    Marangos N; Mausolf A; Ziesmann B
    HNO; 1990 Feb; 38(2):56-8. PubMed ID: 2318669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hearing loss in vestibular schwannomas: analysis of cochlear function by means of distortion-product otoacoustic emissions.
    Ferri GG; Modugno GC; Calbucci F; Ceroni AR; Pirodda A
    Auris Nasus Larynx; 2009 Dec; 36(6):644-8. PubMed ID: 19419826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antioxidant treatment reduces blast-induced cochlear damage and hearing loss.
    Ewert DL; Lu J; Li W; Du X; Floyd R; Kopke R
    Hear Res; 2012 Mar; 285(1-2):29-39. PubMed ID: 22326291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of non-invasive measures to predict cochlear synapse counts.
    Bramhall NF; McMillan GP; Kujawa SG; Konrad-Martin D
    Hear Res; 2018 Dec; 370():113-119. PubMed ID: 30366194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial auditory neuropathy.
    Wang Q; Gu R; Han D; Yang W
    Laryngoscope; 2003 Sep; 113(9):1623-9. PubMed ID: 12972945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evoked otoacoustic emissions: a fundamental and clinical survey.
    Bonfils P; Uziel A; Pujol R
    ORL J Otorhinolaryngol Relat Spec; 1988; 50(4):212-8. PubMed ID: 3050712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.